Oral anticoagulation lowers SLT risk by 58% vs. antiplatelet regimens
Subclinical leaflet thrombosis (SLT) is a “frequent phenomenon” of biological prostheses used in transcatheter aortic valve replacement (TAVR), which, left untreated, raises the risk of unfavorable clinical outcomes such as cerebral ischemic events, according to a new meta-analysis of more than 11,000 patients.